A proposed methodology of cancer risk assessment modeling using biomarkers.
about
Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.Potential application of benzo(a)pyrene-associated adducts (globin or lipid) as blood biomarkers for target organ exposure and human risk assessment.Pharmacokinetics of [14C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.
P2860
A proposed methodology of cancer risk assessment modeling using biomarkers.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
A proposed methodology of cancer risk assessment modeling using biomarkers.
@en
A proposed methodology of cancer risk assessment modeling using biomarkers.
@nl
type
label
A proposed methodology of cancer risk assessment modeling using biomarkers.
@en
A proposed methodology of cancer risk assessment modeling using biomarkers.
@nl
prefLabel
A proposed methodology of cancer risk assessment modeling using biomarkers.
@en
A proposed methodology of cancer risk assessment modeling using biomarkers.
@nl
P2093
P2860
P1476
A proposed methodology of cancer risk assessment modeling using biomarkers.
@en
P2093
Byung Mu Lee
Sun Dong Yoo
P2860
P304
P356
10.1080/15287390252808019
P577
2002-03-01T00:00:00Z